State Laws Public Opinion Wisconsin Mifepristone Iowa Reproductive Rights Abortion Ban State Policies Pro-Life Movement State Rights State Initiatives Referendum State Bans Access Expansion Ballot Initiatives Religious Exemptions Discharge Petition Abortion Pills Florida Abortion Law Late-Term Abortions Hyde Amendment Abortion Rights Veto Uphill Battle Court Rulings Claims Analysis Republican Leadership Women's Rights Medical Malpractice Federal Policies State Level Kentucky Partisan Voting Pro-life Policies Conservative Hardliners Misoprostol Exceptions Federal Law Democratic Pressure Heartbeat Bills Misinformation Viability Standard Florida IVF Access Late-term Abortion Ohio Lawsuit Political Ramifications Supreme Court Healthcare Policy Amendments Roe v. Wade State Measures National Abortion Ban Public Discourse Maine Nebraska State vs Federal Military Legislation Minnesota Law Child Protection Laws Taxpayer Dollars Women's Health Protection Act State Legislation Republican Record Born Alive Infants Protection Act Healthcare North Carolina Ultrasound Informed Consent Act Moderate Republicans State Authority Political Stances Public Misconceptions Nebraska Ballot Measures Impact on Society Pro-life Missouri State State Referendums National Level Contraception Disability Rights Senate
The court stay gives the FDA time to finish a promised safety review of mifepristone.
